Clinical Trials Directory

Trials / Unknown

UnknownNCT02724215

Effect of Sleep Apnea on Blood Pressure Control and Outcome Early After Subarachnoid Hemorrhage

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this observational study patients with subarachnoid hemorrhage (SAH) will be screened for sleep apnea (SA) to investigate if SA is associated with impaired blood pressure control and worse clinical outcome early after SAH.

Detailed description

Patients admitted with non-traumatic SAH will be consented and screened for sleep apnea within 48 hours after hospital admission. Blood pressure and clinical outcome will be monitored throughout ICU treatment and hospital stay, respectively. Diagnosis of sleep apnea will be confirmed on follow-up 3-6 month after SAH by sleep apnea screening (portable cardiorespiratory monitoring and out-of-center polysomnography, respectively).

Conditions

Interventions

TypeNameDescription
DEVICESleep Apnea Screening (Out of Center Polysomnography Device)

Timeline

Start date
2016-03-01
Primary completion
2018-12-01
Completion
2019-03-01
First posted
2016-03-31
Last updated
2017-10-31

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02724215. Inclusion in this directory is not an endorsement.